Oncology navigators see the effects drug policies have on patients firsthand, and AONN+ has been actively engaged in the debates surrounding prescription cancer drug access and pricing. Elizabeth Franklin discusses the need for AONN+ continue its work in patient advocacy and how it is as important now as it has ever been.